Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 2
2018 2
2020 1
2021 1
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Clinical Trial.
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
Verzeroli C, Giaccherini C, Russo L, Bolognini S, Gamba S, Tartari CJ, Schieppati F, Ticozzi C, Vignoli A, Masci G, Sarmiento R, Spinelli D, Malighetti P, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Gasparini G, Minelli M, De Braud F, Santoro A, Labianca R, Marchetti M, Falanga A; HYPERCAN Investigators. Verzeroli C, et al. J Thromb Haemost. 2023 Jul;21(7):1869-1881. doi: 10.1016/j.jtha.2023.03.037. Epub 2023 Apr 11. J Thromb Haemost. 2023. PMID: 37054917 Free article.
Identification of a novel nitroflavone-based scaffold for designing mutant-selective EGFR tyrosine kinase inhibitors targeting T790M and C797S resistance in advanced NSCLC.
Cristina M, Emiliano L, Leonardo S, Giulia S, Roberta G, Adolfo A, Marta SS, Paola S, Samuele R, Pierluigi S, Massimo M, Giovanna M. Cristina M, et al. Among authors: giovanna m. Bioorg Chem. 2022 Dec;129:106219. doi: 10.1016/j.bioorg.2022.106219. Epub 2022 Oct 21. Bioorg Chem. 2022. PMID: 36308853
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.
Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capece M, Lamberti R, Strollo F; Nefrocenter and Nyx Start-up, AMDOSDI Study Group on Injection Techniques, and ANIAD. Gentile S, et al. Adv Ther. 2022 May;39(5):2192-2207. doi: 10.1007/s12325-022-02105-5. Epub 2022 Mar 19. Adv Ther. 2022. PMID: 35306633 Free PMC article. Clinical Trial.
Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study.
Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capece M, Lamberti R, Strollo F; Nefrocenter and Nyx Start-up, AMDOSDI Study Group on Injection Techniques, and ANIAD. Gentile S, et al. Adv Ther. 2022 Jun;39(6):3058. doi: 10.1007/s12325-022-02147-9. Adv Ther. 2022. PMID: 35482252 Free PMC article. No abstract available.
The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study.
Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capace M, Lamberti R, Strollo F; AMD-OSDI Study Group on Injection Technique; Nefrocenter Research and Nyx Start-Up Study Group. Gentile S, et al. Diabetes Ther. 2021 Sep;12(9):2557-2569. doi: 10.1007/s13300-021-01108-9. Epub 2021 Aug 12. Diabetes Ther. 2021. PMID: 34383261 Free PMC article.
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B; OPTIPRIM ANRS-147 Study Group. Chéret A, et al. J Antimicrob Chemother. 2015 Jul;70(7):2108-20. doi: 10.1093/jac/dkv084. Epub 2015 Apr 21. J Antimicrob Chemother. 2015. PMID: 25900157 Clinical Trial.
14 results